BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 30030108)

  • 21. The usefulness of monomeric periostin as a biomarker for idiopathic pulmonary fibrosis.
    Ohta S; Okamoto M; Fujimoto K; Sakamoto N; Takahashi K; Yamamoto H; Kushima H; Ishii H; Akasaka K; Ono J; Kamei A; Azuma Y; Matsumoto H; Yamaguchi Y; Aihara M; Johkoh T; Kawaguchi A; Ichiki M; Sagara H; Kadota JI; Hanaoka M; Hayashi SI; Kohno S; Hoshino T; Izuhara K;
    PLoS One; 2017; 12(3):e0174547. PubMed ID: 28355256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Baseline KL-6 predicts increased risk for acute exacerbation of idiopathic pulmonary fibrosis.
    Ohshimo S; Ishikawa N; Horimasu Y; Hattori N; Hirohashi N; Tanigawa K; Kohno N; Bonella F; Guzman J; Costabel U
    Respir Med; 2014 Jul; 108(7):1031-9. PubMed ID: 24835074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The usefulness of KL-6 and SP-D for the diagnosis and management of chronic hypersensitivity pneumonitis.
    Okamoto T; Fujii M; Furusawa H; Tsuchiya K; Miyazaki Y; Inase N
    Respir Med; 2015 Dec; 109(12):1576-81. PubMed ID: 26481343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomarkers in idiopathic pulmonary fibrosis.
    Drakopanagiotakis F; Wujak L; Wygrecka M; Markart P
    Matrix Biol; 2018 Aug; 68-69():404-421. PubMed ID: 29408012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomarkers to identify ILD and predict lung function decline in scleroderma lung disease or idiopathic pulmonary fibrosis.
    Kennedy B; Branagan P; Moloney F; Haroon M; O'Connell OJ; O'Connor TM; O'Regan K; Harney S; Henry MT
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Sep; 32(3):228-36. PubMed ID: 26422568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calgranulin B and KL-6 in Bronchoalveolar Lavage of Patients with IPF and NSIP.
    Bennett D; Salvini M; Fui A; Cillis G; Cameli P; Mazzei MA; Fossi A; Refini RM; Rottoli P
    Inflammation; 2019 Apr; 42(2):463-470. PubMed ID: 30680696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated CC chemokine level in bronchoalveolar lavage fluid is predictive of a poor outcome of idiopathic pulmonary fibrosis.
    Shinoda H; Tasaka S; Fujishima S; Yamasawa W; Miyamoto K; Nakano Y; Kamata H; Hasegawa N; Ishizaka A
    Respiration; 2009; 78(3):285-92. PubMed ID: 19270434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis.
    Greene KE; King TE; Kuroki Y; Bucher-Bartelson B; Hunninghake GW; Newman LS; Nagae H; Mason RJ
    Eur Respir J; 2002 Mar; 19(3):439-46. PubMed ID: 11936520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma Surfactant Protein-D, Matrix Metalloproteinase-7, and Osteopontin Index Distinguishes Idiopathic Pulmonary Fibrosis from Other Idiopathic Interstitial Pneumonias.
    White ES; Xia M; Murray S; Dyal R; Flaherty CM; Flaherty KR; Moore BB; Cheng L; Doyle TJ; Villalba J; Dellaripa PF; Rosas IO; Kurtis JD; Martinez FJ
    Am J Respir Crit Care Med; 2016 Nov; 194(10):1242-1251. PubMed ID: 27149370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levels of surfactant proteins A and D and KL-6 are elevated in the induced sputum of chronic obstructive pulmonary disease patients: a sequential sputum analysis.
    Ishikawa N; Hattori N; Tanaka S; Horimasu Y; Haruta Y; Yokoyama A; Kohno N; Kinnula VL
    Respiration; 2011; 82(1):10-8. PubMed ID: 21474912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Biomarkers in Idiopathic Pulmonary Fibrosis: State of the Art and Future Directions.
    Stainer A; Faverio P; Busnelli S; Catalano M; Della Zoppa M; Marruchella A; Pesci A; Luppi F
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomarkers in systemic sclerosis-associated interstitial lung disease: review of the literature.
    Bonhomme O; André B; Gester F; de Seny D; Moermans C; Struman I; Louis R; Malaise M; Guiot J
    Rheumatology (Oxford); 2019 Sep; 58(9):1534-1546. PubMed ID: 31292645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of serial serum KL-6 measurements in patients with idiopathic pulmonary fibrosis.
    Wakamatsu K; Nagata N; Kumazoe H; Oda K; Ishimoto H; Yoshimi M; Takata S; Hamada M; Koreeda Y; Takakura K; Ishizu M; Hara M; Ise S; Izumi M; Akasaki T; Maki S; Kawabata M; Mukae H; Kawasaki M
    Respir Investig; 2017 Jan; 55(1):16-23. PubMed ID: 28012488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular classification of idiopathic pulmonary fibrosis: personalized medicine, genetics and biomarkers.
    Hambly N; Shimbori C; Kolb M
    Respirology; 2015 Oct; 20(7):1010-22. PubMed ID: 26109466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The serum KL-6 levels in untreated idiopathic pulmonary fibrosis can naturally decline in association with disease progression.
    Ishii H; Kushima H; Kinoshita Y; Fujita M; Watanabe K
    Clin Respir J; 2018 Sep; 12(9):2411-2418. PubMed ID: 30015394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SP-D, KL-6, and HTI-56 levels in children with mycoplasma pneumoniae pneumonia.
    Shu LH; Lu Q; Han LY; Dong GH
    Int J Clin Exp Pathol; 2015; 8(9):11185-91. PubMed ID: 26617840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Idiopathic Pulmonary Fibrosis: Prospective, Case-Controlled Study of Natural History and Circulating Biomarkers.
    Raghu G; Richeldi L; Jagerschmidt A; Martin V; Subramaniam A; Ozoux ML; Esperet CA; Soubrane C
    Chest; 2018 Dec; 154(6):1359-1370. PubMed ID: 30526970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum level of periostin can predict long-term outcome of idiopathic pulmonary fibrosis.
    Tajiri M; Okamoto M; Fujimoto K; Johkoh T; Ono J; Tominaga M; Azuma K; Kawayama T; Ohta S; Izuhara K; Hoshino T
    Respir Investig; 2015 Mar; 53(2):73-81. PubMed ID: 25745852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Outcome of patients with acute exacerbation of idiopathic interstitial fibrosis (IPF) treated with sivelestat and the prognostic value of serum KL-6 and surfactant protein D].
    Nakamura M; Ogura T; Miyazawa N; Tagawa A; Kozawa S; Watanuki Y; Takahashi H
    Nihon Kokyuki Gakkai Zasshi; 2007 Jun; 45(6):455-9. PubMed ID: 17644940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matrix metalloproteinase-10: a novel biomarker for idiopathic pulmonary fibrosis.
    Sokai A; Handa T; Tanizawa K; Oga T; Uno K; Tsuruyama T; Kubo T; Ikezoe K; Nakatsuka Y; Tanimura K; Muro S; Hirai T; Nagai S; Chin K; Mishima M
    Respir Res; 2015 Sep; 16():120. PubMed ID: 26415518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.